Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases.
Desarkar
Pushpal
P
Das
Anindya
A
Nizamie
S Haque
SH
D000293:Adolescent; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D002220:Carbamazepine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D014268:Trifluoperazine; D002220:Carbamazepine; D000068180:Aripiprazole